Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist, while Wegovy contains semaglutide
The average weight loss in trials was around 14% over 64 weeks at the 25mg dose
Safety Considerations, Side Effects, and Questions to Ask Before Starting Omzo GLP-1 Any article about GLP-1 telehealth that skips the side effects section is doing you a disservice
You can take berberine to support weight loss if you choose, but there are still mixed results in its effectiveness on weight loss outcomes
"However, we note there are a number of significant side effects associated with weight loss medicines," the Ministry of Health spokesperson said, noting that any medication should be reviewed with health care professionals to consider benefits, side effects and possible interactions
There are many insurances that have moved toward not having weight loss management as part of their coverage, leaving many patients to cover the costs out of pocket, says Ackah